Advertisement

Topics

Latest "US Oncology Network" News Stories

01:29 EDT 24th March 2019 | BioPortfolio

Here are the most relevant search results for "US Oncology Network" found in our extensive news archives from over 250 global news sources.

More Information about US Oncology Network on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about US Oncology Network for you to read. Along with our medical data and news we also list US Oncology Network Clinical Trials, which are updated daily. BioPortfolio also has a large database of US Oncology Network Companies for you to search.

Showing "Oncology Network" News Articles 1–25 of 8,400+

Saturday 23rd March 2019

VIDEO | Children's Miracle Network Hospitals Ambassador Chloe Davison Gives A Behind-the-Scenes Peek at the Macy's Thanksgiving Day Parade

SOURCE: Aflac DESCRIPTION:In honor of #ChildrensHospitalsWeek, look at this behind-the-scenes peek at the Macy's Thanksgiving Day Parade with Children's Miracle Network Hospitals Ambassador and


Abbisko Completes $42 Million Series B Funding for Oncology Candidates

Abbisko Therapeutics of Shanghai completed a $42 million series B fundraising led by new investor Qiming, which it will use to start clinical trials of its oncology molecules and expand its discovery pipeline. Later this year, the company expects to start Phase I trials of its two lead candidates, a small molecule FGFR4 inhibitor for hepatocellular carcinoma (HCC) and a CSF1R inhibitor for solid t...

Friday 22nd March 2019

UnitedHealthcare and Optum Take Action to Support People Affected by Flooding in Missouri and Kansas

Assistance for UnitedHealthcare plan participants whose access to care or prescriptions needs may have been affected Free emotional-support help line from Optum open to anyone UnitedHealthcare and Optum, the health benefits and services companies of UnitedHealth Group (NYSE: UNH), are taking action to help people affect...


American Oncology Network, LLC (AON) Introduces Specialty Oral Oncolytic Pharmacy

Community Oncology Patients Benefit from AON In-House Pharmacy Services The American Oncology Network, LLC (AON), an alliance of physicians and seasoned healthcare leaders, provides a unique array of support services to its affiliated community-based oncology practices, including in-house specialty pharmacy services. The AON Pharmacy streamlines the pr...

Gossamer Bio Announces 2018 Annual Financial Results

Gossamer Bio, Inc. (Nasdaq:GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced its financial results for the year ended December 31, 2018 and provided an update on recent corporate developments. ...

Correction: Removal of the MAR plate in the release: The observation status of Oncology Venture is removed

Press release Hørsholm, Denmark and Cambridge, MA, US, March 22, 2019 – Oncology Venture A/S announced today that the observation status for the share on Nasdaq First North has been removed. The decision was taken by Nasdaq Stockholm AB after … Continue reading →

The observation status of Oncology Venture is removed

Press release Hørsholm, Denmark and Cambridge, MA, US, March 22, 2019 – Oncology Venture A/S announced today that the observation status for the share on Nasdaq First North has been removed. The decision was taken by Nasdaq Stockholm AB after … Continue reading →

Life Science Big News Roundup: RISE Announces Hemp-based CBD Products for Sports Recovery and PMS; Kalytera Reports Data for First Cohort in Phase 2 Clinical Study

In case you missed it, here is this week’s life science big news roundup. The post Life Science Big News Roundup: RISE Announces Hemp-based CBD Products for Sports Recovery and PMS; Kalytera Reports Data for First Cohort in Phase 2 Clinical Study appeared first on Investing News Network.

bluebird bio Opens State-of-the-Art Gene and Cell Therapy Manufacturing Facility

bluebird bio (NASDAQ:BLUE) has announced the opening of its first wholly owned manufacturing facility in Durham, North Carolina, which will produce lentiviral vector for its investigational gene and cell therapies. As quoted in the press release: Gov. Roy Cooper, Secretary of Commerce Tony Copeland and local patient advocates will join chief bluebird Nick Leschly in … Continued The post

VCA Charities partners with VCA Animal Hospitals for Third Annual “Pennies for Pets” Campaign

Over $1 million donated in first two years of program to benefit companion animals nationally VCA Animal Hospitals, the nation’s largest network of freestanding animal hospitals, and its nonprofit partner organization VCA Charities, have come together again to raise awareness and funds for worthy companion animal nonprofits. In their successful annua...

Sorrento Therapeutics Announces Merger of Scilex and Semnur

Sorrento Therapeutics (NASDAQ:SRNE) has announced its majority-owned subsidiary Scilex Pharmaceuticals will merge with Semnur Pharmaceuticals to form a new company, Scilex Holding Company. As quoted in the press release: Sorrento’s equity stake in Scilex (77%) has been converted into a 58% stake in Scilex Holding. With Scilex’s lead product ZTlido® (lidocaine topical system 1.8%) ramping R...

Current State of Value-based Care in Oncology: 13 Key Trends to Know

New data on the state of value-based care in oncology has found that while community oncologists are optimistic about the beneficial potential of value-based care, they see a conflict between the need to decrease episode costs and the rising prices of the most innovative novel therapies. In an effort to dig deeper into current attitudes ... Read More

resTORbio Announces Closing Public Offering of Common Stock

resTORbio (NASDAQ:TORC) has announced the closing of a previously announced underwritten public offering of 7.2 million shares of its common stock at a price of US$6.95 per share. As quoted in the press release:  resTORbio also granted the underwriters a 30-day option to purchase up to an additional 1,080,000 shares of common stock at the … Continued The post resTORbio Announces Closing Pub...

Fishawack acquires Dudnyk

Agency to boost abilities in rare diseases and oncology

Cerveau Technologies Inc. Signs Research Agreement with Eisai Inc., for Novel Tau Imaging Agent

Cerveau Technologies, Inc. today announced a research collaboration agreement with Eisai Inc., which will enable Eisai to use Cerveau’s [F-18]MK-6240, an investigational imaging agent, in Positron Emission Tomography (PET) scans to assess the status and progression of neurofibrillary tangles (NFTs) in the brain. NFTs made up of aggregated tau protein are...

LegoChem and Takeda Partner for the Development of Antibody-Drug Conjugates in Immuno-Oncology

DAEJEON, South Korea–(BUSINESS WIRE)–LegoChem Biosciences, Inc. (“LCB”) (KOSDAQ:141080) announced today that it has entered a research collaboration and license agreement with Takeda Pharmaceutical Company Limited (“Takeda”) for the development of antibody-drug conjugates in immuno-oncology. Takeda gains certain rights to LCB’s antibody-drug conjugate (ADC) technology, C...

FDA Warns About the Risks Associated with the Investigational Use of Venclexta in Multiple Myeloma

[3/21/2019] The U.S. Food and Drug Administration is alerting health care professionals, oncology clinical investigators and patients about the risks associated with the investigational use of Venclexta (venetoclax) for the treatment of patients with multiple myeloma based on data from a clinical trial. Venclexta is not approved for the treatment of multiple myeloma. FDA reviewed data …

OncLive® Presents State of the Science Summit™ on Ovarian Cancer and Soft Tissue Sarcoma

The summit will feature expert faculty from Memorial Sloan Kettering Cancer Center OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, will host its latest State of the Science Summit™ on ovarian cancer and soft tiss...

NCCN 2019

Read clinically focused news coverage of key developments from NCCN 2019 Medscape Oncology

Long-term use of inexpensive weight-loss drug may be safe and effective

An inexpensive weight-loss drug approved 60 years ago for only short-term use also may be safe and effective for longer-term treatment, according to a study conducted by researchers at Wake Forest Baptist Health and the Patient Outcomes Research to Advance Learning network.

EBMT 2019

Read clinically focused news coverage of key developments from EBMT 2019 Medscape Oncology

UnitedHealthcare Launches National Vision Laboratory Network Relationship with Essilor Labs

UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, has launched a national vision laboratory network to better serve eye care professionals and meet the needs of more than 19 million vision plan participants. The laboratory network has launched in collaboration with Essilor, which operates the largest optical lab network in the country. T...

SoFi and Delos Partner to Bring Delos’ Home Wellness Solutions to Homeowners

The partnership will help drive accessibility of Delos’ health and wellness technology to homes across the U.S. Wellness real estate and technology company, Delos™, is collaborating with online personal finance company, SoFi, to ensure homeowners will have an accessible financing path to implement Delos’ DARWIN Home Wellness Intelligence Network,...

Trueman Man Clinic Achieves 10000 Surgery Milestone with Its SWITCH Operation

Trueman Man Clinic Network announced that the 10,000th surgery utilizing its SWITCH Premature Ejaculation Surgery (Nerve Conservation), has been successfully completed. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190322005013/en/

Celgene and Exscientia sign AI drug discovery deal in oncology and autoimmunity

Firm says it cuts discovery timelines by 75%


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks